Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 327

1.

Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.

Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, Gibbs IC, Fisher GA, Koong AC.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):486-93. doi: 10.1016/j.ijrobp.2009.08.020. Epub 2010 Mar 28.

PMID:
20350791
[PubMed - indexed for MEDLINE]
2.

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.

Méndez Romero A, Wunderink W, Hussain SM, De Pooter JA, Heijmen BJ, Nowak PC, Nuyttens JJ, Brandwijk RP, Verhoef C, Ijzermans JN, Levendag PC.

Acta Oncol. 2006;45(7):831-7.

PMID:
16982547
[PubMed - indexed for MEDLINE]
3.

Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy.

Dewas S, Bibault JE, Mirabel X, Fumagalli I, Kramar A, Jarraya H, Lacornerie T, Dewas-Vautravers C, Lartigau E.

Radiat Oncol. 2012 Oct 10;7:166. doi: 10.1186/1748-717X-7-166.

PMID:
23050794
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

[Stereotactic body radiation therapy for liver primary and metastases: the Lille experience].

Dewas S, Mirabel X, Kramar A, Jarraya H, Lacornerie T, Dewas-Vautravers C, Fumagalli I, Lartigau É.

Cancer Radiother. 2012 Feb;16(1):58-69. doi: 10.1016/j.canrad.2011.06.005. Epub 2011 Dec 30. French.

PMID:
22209710
[PubMed - indexed for MEDLINE]
5.

Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.

Huang WY, Jen YM, Lee MS, Chang LP, Chen CM, Ko KH, Lin KT, Lin JC, Chao HL, Lin CS, Su YF, Fan CY, Chang YW.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):355-61. doi: 10.1016/j.ijrobp.2011.11.058. Epub 2012 Feb 17.

PMID:
22342300
[PubMed - indexed for MEDLINE]
6.

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.

Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE.

J Clin Oncol. 2009 Apr 1;27(10):1572-8. doi: 10.1200/JCO.2008.19.6329. Epub 2009 Mar 2.

PMID:
19255321
[PubMed - indexed for MEDLINE]
7.

Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, Sherman M, Dawson LA.

J Clin Oncol. 2008 Feb 1;26(4):657-64. doi: 10.1200/JCO.2007.14.3529. Epub 2008 Jan 2. Erratum in: J Clin Oncol. 2008 Aug 10;26(23):3911-2.

PMID:
18172187
[PubMed - indexed for MEDLINE]
8.

Stereotactic radiotherapy of primary liver cancer and hepatic metastases.

Wulf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K, Flentje M.

Acta Oncol. 2006;45(7):838-47.

PMID:
16982548
[PubMed - indexed for MEDLINE]
9.

Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.

Siddiqui F, Patel M, Khan M, McLean S, Dragovic J, Jin JY, Movsas B, Ryu S.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1047-53. doi: 10.1016/j.ijrobp.2008.09.022. Epub 2009 Mar 26.

PMID:
19327895
[PubMed - indexed for MEDLINE]
10.

Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.

Cárdenes HR, Price TR, Perkins SM, Maluccio M, Kwo P, Breen TE, Henderson MA, Schefter TE, Tudor K, Deluca J, Johnstone PA.

Clin Transl Oncol. 2010 Mar;12(3):218-25. doi: 10.1007/s12094-010-0492-x.

PMID:
20231127
[PubMed - indexed for MEDLINE]
11.

Hypofractionated stereotactic body radiotherapy for primary and metastatic liver tumors using the novalis image-guided system: preliminary results regarding efficacy and toxicity.

Iwata H, Shibamoto Y, Hashizume C, Mori Y, Kobayashi T, Hayashi N, Kosaki K, Ishikawa T, Kuzuya T, Utsunomiya S.

Technol Cancer Res Treat. 2010 Dec;9(6):619-27.

PMID:
21070084
[PubMed - indexed for MEDLINE]
12.

Stereotactic body radiotherapy for primary hepatocellular carcinoma.

Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, Johnstone PA, Cardenes HR.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e447-53. doi: 10.1016/j.ijrobp.2011.04.011. Epub 2011 Jun 7.

PMID:
21645977
[PubMed - indexed for MEDLINE]
13.

A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.

Fumagalli I, Bibault JE, Dewas S, Kramar A, Mirabel X, Prevost B, Lacornerie T, Jerraya H, Lartigau E.

Radiat Oncol. 2012 Sep 27;7:164. doi: 10.1186/1748-717X-7-164.

PMID:
23014094
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.

Ben-Josef E, Normolle D, Ensminger WD, Walker S, Tatro D, Ten Haken RK, Knol J, Dawson LA, Pan C, Lawrence TS.

J Clin Oncol. 2005 Dec 1;23(34):8739-47.

PMID:
16314634
[PubMed - indexed for MEDLINE]
15.

Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma.

Seo YS, Kim MS, Yoo SY, Cho CK, Choi CW, Kim JH, Han CJ, Park SC, Lee BH, Kim YH, Lee DH.

J Surg Oncol. 2010 Sep 1;102(3):209-14. doi: 10.1002/jso.21593.

PMID:
20740576
[PubMed - indexed for MEDLINE]
16.

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):291-8.

PMID:
10802351
[PubMed - indexed for MEDLINE]
17.

Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.

Son SH, Choi BO, Ryu MR, Kang YN, Jang JS, Bae SH, Yoon SK, Choi IB, Kang KM, Jang HS.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1073-80. doi: 10.1016/j.ijrobp.2009.09.009. Epub 2010 Mar 6.

PMID:
20207492
[PubMed - indexed for MEDLINE]
18.

Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors.

Ibarra RA, Rojas D, Snyder L, Yao M, Fabien J, Milano M, Katz A, Goodman K, Stephans K, El-Gazzaz G, Aucejo F, Miller C, Fung J, Lo S, Machtay M, Sanabria JR.

Acta Oncol. 2012 May;51(5):575-83. doi: 10.3109/0284186X.2011.652736. Epub 2012 Jan 23.

PMID:
22263926
[PubMed - indexed for MEDLINE]
19.

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, Cummings B, Ringash J, Tse RV, Knox JJ, Dawson LA.

J Clin Oncol. 2009 Apr 1;27(10):1585-91. doi: 10.1200/JCO.2008.20.0600. Epub 2009 Mar 2.

PMID:
19255313
[PubMed - indexed for MEDLINE]
20.

A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.

Robertson JM, McGinn CJ, Walker S, Marx MV, Kessler ML, Ensminger WD, Lawrence TS.

Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1087-92.

PMID:
9392548
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk